Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 27Breast Neoplasms 23Ovarian Neoplasms 19Triple Negative Breast Neoplasms 17Endometrial Neoplasms 16Lung Neoplasms 15Parkinson Disease 4, Autosomal Dominant Lewy Body 12Fallopian Tube Neoplasms 11Squamous Cell Carcinoma of Head and Neck 9Neoplasm Metastasis 9Neoplasms 6Esophageal Neoplasms 6Adenocarcinoma Of Esophagus 6Stomach Neoplasms 4Melanoma 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Uterine Cervical Neoplasms 3Colorectal Neoplasms 3Carcinoma 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Peritoneal Neoplasms 2Pathologic Complete Response 2Head and Neck Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Brenner Tumor 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Solid Tumour 2

Interventions

Nivolumab 2sacituzumab govitecan 1relatlimab 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1avelumab 1Vinblastine 1Specimen Handling 1Paclitaxel 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Disulfides 1Cystoscopy 1Cisplatin 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscle Invasive Bladder Urothelial Carcinoma × Paclitaxel × 30 days × Clear all
NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡